Biotech6 hours ago
Flomics Biotech Develops RNA-Based Blood Test for Early Cancer Detection
Flomics Biotech’s liquid biopsy detects five cancers—colon, lung, prostate, pancreas, and breast—with 92% accuracy. Using RNA biomarkers, AI, and next-generation sequencing, it identifies early-stage cancer with...